Top Markets
Coin of the day
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

600866
주식 순위 #9223
Established in 1964 and headquartered in Zhaoqing, China, Star Lake Bioscience... Established in 1964 and headquartered in Zhaoqing, China, Star Lake Bioscience Co., Inc. specializes in the production and global distribution of pharmaceutical ingredients, as well as food and animal feed additives. Its extensive product catalog includes guanosine, which serves as a crucial intermediate for both food and pharmaceutical applications. The company also manufactures L-proline, a vital intermediate for synthesizing captopril and enalapril, and a raw material used in amino acid transfusions. Another key offering is Adefovir dipivoxil tablets, formulated to combat Hepatitis B by inhibiting HBV DNA polymerase activity and disrupting the virus's DNA. Additionally, L-threonine is provided for its application in animal feed premixes, particularly for pigs and poultry. Star Lake Bioscience further supplies disodium 5'-ribonucleotide, utilized in the treatment of chronic hepatitis, muscular atrophy, and certain eye conditions. Similarly, disodium 5-inosinate addresses issues like leukopenia, thrombocytopenia, and both acute and chronic hepatitis. Inosine is another significant product, prescribed for various ailments including chronic hepatitis, heart disease, low white blood cell or platelet counts, and central choroidoretinitis. Furthermore, disodium 5'-guanylate finds application in food preservation, such as for canned meats, ham, and other salted meat products. The company's broad portfolio also features compounds such as ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, and L-lysine, among others. These diverse offerings are marketed under the proprietary brands Star Lake and Yue Bao.
주가
$0.63907023
마지막 동기화: 2026-08-28
시가총액
$1.06B
변동 (1일)
1.15%
변동 (1년)
-44.43%
국가
CN
거래 Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866)

카테고리

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866)의 발행 주식 수
August 2026 기준 발행 주식 수: 0
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 0입니다. August 2026 말 기준 회사는 0주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866)의 발행 주식 수 기록 (2026 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
253.90M -
US
62.19M -
NL
478.91M -
AU
396.00M -
US
- -
CH